Psychopharmacology with adolescents: a current review.
D000293:Adolescent; D000662:Amphetamines / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002090:Butyrophenones; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D008774:Methylphenidate / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010640:Phenothiazines; D010879:Piperazines / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use*
D000662:Amphetamines; D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D002090:Butyrophenones; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D010879:Piperazines; D011619:Psychotropic Drugs; D008774:Methylphenidate; D008094:Lithium